SEC 13F Intelligence

Capstone Investment Advisors, LLC / IMMU

Capstone Investment Advisors, LLC’s Immunomedics Inc Position

Does Capstone Investment Advisors, LLC own Immunomedics Inc (IMMU)? Not currently — the last reported position was 850.8K shares worth $72M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$72M
Q3 2020
Shares
850.8K
% of Portfolio
+0.37%
Quarters Held
1
position exited

Position History IMMU

Reported value by quarter
Q3 ’20: $72MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2020850.8K$72M+0.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capstone Investment Advisors, LLC’s full portfolio or all institutional holders of IMMU.